Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC and Bristol-Myers Squibb Co Complete Acquisition of Rights for Byetta and Bydureon from Eli Lilly And Co


Monday, 1 Apr 2013 03:00am EDT 

AstraZeneca PLC and Bristol-Myers Squibb Co announced that they completed the acquisition of rights to Byetta (exenatide) and Bydureon (exenatide) from Eli Lilly And Co. AstraZeneca and Bristol-Myers Squibb started in January 2007 a diabetes alliance and a cooperation on research, development and sale for certain products for type 2 diabetes. 

Company Quote

4572.5
123.5 +2.78%
18 Dec 2014